Bayer's CEO to step down by 2016

Singapore: German drugmaker Bayer announced that Dr Marjin Dekkers will step down as the CEO, by the end of 2016. The fi...

June 5, 2014 | Thursday | News
Lupin gets FDA approval for Lyrica generic

Mumbai: Pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received final approval for its pregabalin capsules,...

July 6, 2012 | Friday | Regulatory
Indian state to slash prices of 348 drugs

Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's d...

July 23, 2013 | Tuesday | News
Daiichi to work with US FDA to solve Ranbaxy quality issue

Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the...

September 25, 2013 | Wednesday | News
Ranbaxy aiming to sell its generics in Japan

Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma...

November 18, 2013 | Monday | News
Ranbaxy claims FDA form '483' not a show stopper

Singapore: Soon after reports of Ranbaxy's Mohali manufacturing plant being issued a Form 483 by the US US FDA broke out...

June 28, 2013 | Friday | News
Astellas joins hands with Tecnofarma International

Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecno...

June 7, 2013 | Friday | News
Generic sodium tablets from Dr. Reddy's, Mylan hit US market

Mumbai: Dr. Reddy's Laboratories, India's leading pharmaceutical company, recently launched Montelukast Sodium Tablets a...

August 8, 2012 | Wednesday | News
Generics take center stage in South East Asia

Singapore: The South East Asian pharmaceuticals industry is forecast to witness a boost to $3.9 billion by 2016. The in...

August 21, 2013 | Wednesday | Analysis
China: GSK used sexual bribery to boost sales

Singapore: The police in China have made it official that four senior Chinese executives of GlaxoSmithKline have been de...

July 15, 2013 | Monday | News
Mayne Pharma acquires generic drugmaker Libertas

Singapore: Mayne Pharma from Australia has made a second US acquisition by buying privately-held US-based generic drugma...

July 5, 2013 | Friday | News
Bribery inquiries rising in China: SPP

Singapore: Chinese prosecutors have received more than 600,000 inquiries about bribery records involving companies or in...

July 15, 2013 | Monday | News
China bans GSK finance head from leaving country

Singapore: Even as police in China are investigating claims of bribery against the British drug major for bribing doctor...

July 18, 2013 | Thursday | News
UCB sues 15 firms for patent infringement

Singapore: In a move that is threatening to become a high profile patent infringement suit, global biopharma company UCB...

July 24, 2013 | Wednesday | News
Deregulation will boost Japanese pharma sector

Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent o...

June 4, 2013 | Tuesday | News
50% of all drug firms have counter-generics team

Singapore: A report by Cutting Edge Information titled, 'Post-patent generic and biosimilar defense: Harnessing competit...

August 26, 2013 | Monday | News
Diabetes drug Actos banned in India

Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain...

July 10, 2013 | Wednesday | Regulatory
Reports: GSK staff detained in 'fraud data' case in China

Singapore: The Chinese police have reportedly detained employees of British pharmaceuticals major GlaxoSmithKline (GSK) ...

July 1, 2013 | Monday | News